Guidance
Reporting adverse incidents: joint replacement implants
For manufacturers reporting adverse incidents with joint replacement implants under the vigilance system.
Documents
Details
Guidance for manufacturers on reporting adverse incidents involving joint replacement implants under the vigilance system
To be read in conjunction with the guidelines on post-market surveillance.
Updates to this page
Published 1 June 2008Last updated 15 January 2025 + show all updates
-
Updated to reflect the laying of The Medical Devices (Post-market Surveillance requirements) (Amendment) Regulations 2024.
-
This page has been updated due to the end of the transition period.
-
First published.